Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations

Niels Herluf Paulsen*, Camilla Qvortrup, Fie Juhl Vojdeman, Peter Plomgaard, Stig Ejdrup Andersen, Anne Ramlov, Birgitte Bertelsen, Maria Rossing, Claus Gyrup Nielsen, Elke Hoffmann-Lücke, Eva Greibe, Hanne Spangsberg Holm, Heidi Hvid Nielsen, Ihab Bishara Yousef Lolas, Jonna Skov Madsen, Marianne Lerbaek Bergmann, Morten Mørk, Palle B.Nielsen Fruekilde, Pernille Bøttger, Peter Clausager PetersenPeter Henrik Nissen, Søren Feddersen, Troels K. Bergmann, Per Pfeiffer, Per Damkier

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

4 Citations (Scopus)
Original languageEnglish
JournalActa Oncologica
Volume61
Issue11
Pages (from-to)1400-1405
Number of pages6
ISSN0284-186X
DOIs
Publication statusPublished - Nov 2022

Keywords

  • Denmark/epidemiology
  • Dihydrouracil Dehydrogenase (NADP)/genetics
  • Fluorouracil
  • Genotype
  • Humans
  • Neoplasms/epidemiology
  • Phenotype
  • Prevalence
  • Uracil

Cite this